The SMART Trial: Modified Single-Stapled Anastomosis in Laparoscopic or Robotic Low Anterior Resection for Rectal Cancer
MST
Modified Single-Stapled Anastomosis in Laparoscopic or Robotic Low Anterior Resection for Rectal Cancer: The SMART Trial (Single-Modified Anastomosis for Rectal Cancer Surgery Technique), A Multicenter Randomized Controlled Study
1 other identifier
interventional
450
1 country
6
Brief Summary
The goal of this clinical trial is to learn whether a modified single-stapled anastomosis (MST) can reduce anastomotic leakage compared with the conventional double-stapled technique (DST) in adult patients undergoing laparoscopic or robotic low anterior resection for rectal cancer. The main questions it aims to answer are:
- Does MST lower the incidence of anastomotic leakage after rectal cancer surgery?
- Does MST improve short-term surgical outcomes compared with DST? Researchers will compare the MST group with the DST group to see if MST leads to fewer anastomotic leaks and safer postoperative recovery. Participants will: Receive either MST or DST during minimally invasive rectal cancer surgery Undergo routine postoperative CT scans within one month after surgery to check for symptomatic or asymptomatic anastomotic leakage Attend scheduled follow-up visits and standard postoperative assessments as part of routine rectal cancer care
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2025
Longer than P75 for not_applicable
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 3, 2025
CompletedStudy Start
First participant enrolled
December 20, 2025
CompletedFirst Posted
Study publicly available on registry
January 29, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 30, 2030
January 29, 2026
January 1, 2026
2 years
December 3, 2025
January 26, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Anastomotic leakage
Anastomotic leakage will be assessed within 30 days after surgery using clinical evaluation and routine abdominopelvic computed tomography (APCT). Leakage is defined as any defect in the anastomosis that results in communication between the inside of the bowel and the surrounding tissue. Diagnostic criteria include clinical symptoms (such as fever, abdominal pain, or drainage contents), abnormal laboratory findings, or radiologic evidence of leakage on APCT. All leaks will be classified according to the grading system. * Grade A: Leakage requiring no active therapeutic intervention. * Grade B: Leakage requiring non-surgical management, such as antibiotics or percutaneous drainage. * Grade C: Leakage requiring reoperation. Routine postoperative CT for all participants ensures consistent and standardized detection of both symptomatic and asymptomatic leaks.
within 30 days after surgery
Study Arms (2)
Modified single-stapled anastomosis technique
EXPERIMENTALParticipants assigned to this arm will undergo minimally invasive low anterior resection using the modified single-stapled technique. After rectal resection, the two ends of the linear staple line of stump are approximated toward the center using a barbed suture. The circular stapler spike is introduced through the center of the staple line to ensure complete resection of the linear staple line, eliminating staple-line intersections. The reaminder of the procedure, including total mesorectal excision, follows standard oncologic principles.
Double-stapled anastomosis technique
NO INTERVENTIONParticipants assigned to this arm will undergo minimally invasive low anterior resection using the conventional double-stapled technique. The rectum is transected with linear stapler, followed by transanal introduction of a circular stapler to create an end-to-end anastomosis. The procedure represents current standard practice for low anterior resection in rectal cancer.
Interventions
This intervention applies a modified single-stapled anastomosis specifically to low anterior resection (LAR), where the technique has not been previously evaluated in a randomized controlled trial. Although similar concepts have been explored in anterior resection, their application in LAR is technically more challenging due to the deeper pelvic working space and more limited access to the rectal stump. In earlier studies, approximation of the linear staple line was performed through a Pfannelstein incision or mini-laparotomy incision during specimen extraction. In contrast, this trial utilizes a fully intracorporeal approach.
Eligibility Criteria
You may qualify if:
- Adult patients with rectal cancer who are scheduled to undergo laparoscopic or robotic low anterior resection
- histologically confirmed rectal adenocarcinoma located within 15cm from anal verge.
- ECOG performance status of 0 to 2
- Any clinical stage
You may not qualify if:
- Who have significant comorbidities or history of abdominal surgeries that would preclude a minimally invasive approach
- Bowel obstruction for perforation requiring emergency surgey
- Concurrent, or recent treatment for colorectal or other malignancies within the past five years
- Presence of inflammatory bowel diseases
- Hereditary colorectal cancer syndrome
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Korea University Anam Hospitallead
- Kyunghee University Medical Centercollaborator
- Seoul National University Hospitalcollaborator
- Kyungpook National University Chilgok Hospitalcollaborator
- Saint Vincent's Hospital, Koreacollaborator
- Sinchon Severance Hospital, Yonsei University College of Medicinecollaborator
Study Sites (6)
St. Vincent's Hospital
Suwon, Gyeonggi-do, 16247, South Korea
Kyungpook National University Chilgok Hospital
Daegu, Gyeongsangbuk-do, 41404, South Korea
Kyung Hee University Hospital
Seoul, 02447, South Korea
Korea University Anam Hospital
Seoul, 02841, South Korea
Seoul National University Hospital
Seoul, 03080, South Korea
Severance Hospital
Seoul, 03722, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jin Kim, M.D., Ph.D
Korea University Anam Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- No additional parties.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
December 3, 2025
First Posted
January 29, 2026
Study Start
December 20, 2025
Primary Completion (Estimated)
December 30, 2027
Study Completion (Estimated)
December 30, 2030
Last Updated
January 29, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share
IPD will not be shared because the dataset contains sensitive clinical information, and secondary distribution is not permitted under the terms of institutional review board approvals and patient consent. Data access is restricted to the study investigators to protect participant privacy.